Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products

Research Paper, December 2011

This South Centre Research Paper is a contribution to the debate and reform process of the WHO to enable it to respond to the health and health policy challenges of the twenty-first century. More specifically, this paper addresses the issue of the pharmaceutical innovation system within the perspective of access to medicines, exploring possible structural changes in the current system. To do so, it addresses the question of how the constitutional powers of the WHO, often ignored by the Organization itself, can contribute positively to a paradigm shift in biomedical research stimulation.

Click here to access the paper.

This entry was posted in Innovation and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s